257 related articles for article (PubMed ID: 21378078)
1. The role of 18F-fluorodeoxyglucose positron emission tomography in thyroid neoplasms.
Lang BH; Law TT
Oncologist; 2011; 16(4):458-66. PubMed ID: 21378078
[TBL] [Abstract][Full Text] [Related]
2. A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.
Choi JS; Choi Y; Kim EK; Yoon JH; Youk JH; Han KH; Moon HJ; Kang WJ; Kwak JY
Ultraschall Med; 2014 Feb; 35(1):51-8. PubMed ID: 24458573
[TBL] [Abstract][Full Text] [Related]
3. Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology?
Deandreis D; Al Ghuzlan A; Auperin A; Vielh P; Caillou B; Chami L; Lumbroso J; Travagli JP; Hartl D; Baudin E; Schlumberger M; Leboulleux S
Thyroid; 2012 Feb; 22(2):165-72. PubMed ID: 22257371
[TBL] [Abstract][Full Text] [Related]
4. Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis.
Traugott AL; Dehdashti F; Trinkaus K; Cohen M; Fialkowski E; Quayle F; Hussain H; Davila R; Ylagan L; Moley JF
World J Surg; 2010 Jun; 34(6):1247-53. PubMed ID: 20140435
[TBL] [Abstract][Full Text] [Related]
5. The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer.
Eloy JA; Brett EM; Fatterpekar GM; Kostakoglu L; Som PM; Desai SC; Genden EM
AJNR Am J Neuroradiol; 2009 Aug; 30(7):1431-4. PubMed ID: 19342543
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography.
Salvatori M; Melis L; Castaldi P; Maussier ML; Rufini V; Perotti G; Rubello D
Biomed Pharmacother; 2007 Sep; 61(8):488-93. PubMed ID: 17604940
[TBL] [Abstract][Full Text] [Related]
7. Review. 18F-FDG PET in the diagnosis and follow-up of thyroid malignancy.
Al-Nahhas A; Khan S; Gogbashian A; Banti E; Rampin L; Rubello D
In Vivo; 2008; 22(1):109-14. PubMed ID: 18396792
[TBL] [Abstract][Full Text] [Related]
8. Indeterminate thyroid cytology in an iodine-deficient population: Prevalence, operation rate, risk of malignancy anddiagnostic value of thyroid scintigraphy and
Almasi CE; Frandsen AP; Erentaite D; Duch K; Zacho HD
Hell J Nucl Med; 2023; 26(1):2-8. PubMed ID: 37031417
[TBL] [Abstract][Full Text] [Related]
9. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
Kim TY; Kim WB; Ryu JS; Gong G; Hong SJ; Shong YK
Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
[TBL] [Abstract][Full Text] [Related]
10. [Preoperative evaluation of cytologically indeterminate thyroid nodules with 18F-FDG PET].
Sebastianes FM; Cerci JJ; Soares Júnior J; Zanoni PH; Tomimori EK; Camargo RY; Meneghetti JC; Pereira MA
Arq Bras Endocrinol Metabol; 2008 Oct; 52(7):1176-83. PubMed ID: 19082307
[TBL] [Abstract][Full Text] [Related]
11. Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values.
Brindle R; Mullan D; Yap BK; Gandhi A
Eur J Surg Oncol; 2014 Nov; 40(11):1528-32. PubMed ID: 24915858
[TBL] [Abstract][Full Text] [Related]
12. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules.
Sebastianes FM; Cerci JJ; Zanoni PH; Soares J; Chibana LK; Tomimori EK; de Camargo RY; Izaki M; Giorgi MC; Eluf-Neto J; Meneghetti JC; Pereira MA
J Clin Endocrinol Metab; 2007 Nov; 92(11):4485-8. PubMed ID: 17684046
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Sager S; Vatankulu B; Sahin OE; Cınaral F; Uslu L; Baran A; Ozturk T; Sönmezoglu K
J Cancer Res Ther; 2018; 14(5):989-993. PubMed ID: 30197336
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach.
Vriens D; Adang EM; Netea-Maier RT; Smit JW; de Wilt JH; Oyen WJ; de Geus-Oei LF
J Clin Endocrinol Metab; 2014 Sep; 99(9):3263-74. PubMed ID: 24873995
[TBL] [Abstract][Full Text] [Related]
15. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
[TBL] [Abstract][Full Text] [Related]
16. Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?
Hales NW; Krempl GA; Medina JE
Am J Otolaryngol; 2008; 29(2):113-8. PubMed ID: 18314022
[TBL] [Abstract][Full Text] [Related]
17. Focal Thyroid Incidentalomas on
de Leijer JF; Metman MJH; van der Hoorn A; Brouwers AH; Kruijff S; van Hemel BM; Links TP; Westerlaan HE
Front Endocrinol (Lausanne); 2021; 12():723394. PubMed ID: 34744999
[TBL] [Abstract][Full Text] [Related]
18. Possible role of F18-FDG-PET/CT in differentiating benign lesions versus malignant after indeterminate fine-needle aspiration cytology. a wider and still controversial issue: exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis.
Bertagna F; Giubbini R
World J Surg; 2011 May; 35(5):1146-7; author reply 1148-9. PubMed ID: 21088836
[No Abstract] [Full Text] [Related]
19. Molecular Diagnostics and [
de Koster EJ; Morreau H; Bleumink GS; van Engen-van Grunsven ACH; de Geus-Oei LF; Links TP; Wakelkamp IMMJ; Oyen WJG; Vriens D
Thyroid; 2024 Jan; 34(1):41-53. PubMed ID: 38009209
[No Abstract] [Full Text] [Related]
20. Hounsfield unit value has null effect on thyroid nodules at 18F-FDG PET/CT scans.
Haydardedeoglu FE; Bagir GS; Torun N; Kocer E; Reyhan M; Ertorer ME
Arch Endocrinol Metab; 2018 Aug; 62(4):460-465. PubMed ID: 30304111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
